Microgenics Corporation

Microgenics Corporation — FDA 510(k) Submissions

Microgenics Corporation has submitted 21 FDA 510(k) premarket notifications since 2009, of which 20 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Enzyme Immunoassay, Opiates, Enzyme Immunoassay, Benzodiazepine, Enzyme Immunoassay, Cocaine And Cocaine Metabolites, U.v. Spectrometry, Tricyclic Antidepressant Drugs, Multi-analyte Controls, All Kinds (assayed) . Use the specialty filter in the sidebar to narrow results.